Association of Reduced Tumor Necrosis Factor Alpha, Gamma Interferon, and Interleukin-1β (IL-1β) but Increased IL-10 Expression with Improved Chest Radiography in Patients with Pulmonary Tuberculosis
Authors:
Open Access
- 1 February 2010
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 17 (2) , 223-231
Abstract
Mycobacterium tuberculosisinfection is a major world health issue. The early identification of patients at risk for a poor response to anti-M. tuberculosistherapy would help elucidate the key players in the anti-M. tuberculosisresponse. The objective of the present study was to correlate the modulation of cytokine expression (interleukin-1 [IL-1], IL-6, IL-8, IL-10, IL-12, gamma interferon [IFN-γ], interferon-inducible protein [IP-10], and monocyte chemotactic protein 1 [MCP-1]) with the clinical response to 2 months of intensive therapy. From January to December 2007, 40M. tuberculosis-infected patients and 40 healthy patients were recruited. After exclusion for diabetes, 32 patients and 36 controls were analyzed. The clinical responses of theM. tuberculosis-infected patients on the basis of the findings of chest radiography were compared to their plasma cytokine levels measured before and after 2 months of intensive anti-M. tuberculosistherapy and 6 months of therapy with human cytokine antibody arrays. Chest radiographs of 20 of 32M. tuberculosis-infected patients showed improvement after 2 months of intensive therapy (early responders), while theM. tuberculosisinfections in 12 of 32 of the patients resolved after a further 4 months (late responders). The levels of expression of TNF-α, MCP-1, IFN-γ, and IL-1β were decreased; and the level of IL-10 increased in early responders. After adjustment for age, gender, and the result of sputum culture forM. tuberculosis, significant differences in the levels of MCP-1 and IP-10 expression were observed between the early and the late responders after 2 months of intensive anti-M. tuberculosistherapy. Due to the interpatient variability in IP-10 levels, intrapatient monitoring of IP-10 levels may provide more insight into theM. tuberculosisresponder status than comparison between patients. Plasma MCP-1 levels were normalized in patients who had resolved theirM. tuberculosisinfections. Further studies to evaluate the association of the modulation in MCP-1 levels with early and late responses are warranted.Keywords
This publication has 33 references indexed in Scilit:
- IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assayBMC Research Notes, 2009
- In Vitro Levels of Interleukin 10 (IL-10) and IL-12 in Response to a Recombinant 32-Kilodalton Antigen ofMycobacterium bovisBCG after Treatment for TuberculosisClinical and Vaccine Immunology, 2009
- Severe Tuberculosis Induces Unbalanced Up‐Regulation of Gene Networks and Overexpression ofIL‐22, MIP‐1α, CCL27, IP‐10, CCR4, CCR5, CXCR3, PD1, PDL2, IL‐3, IFN‐β, TIM1,andTLR2but Low Antigen‐Specific Cellular ResponsesThe Journal of Infectious Diseases, 2008
- RETRACTED: Restoration of Impaired Free Radical Generation and Proinflammatory Cytokines by MCP‐1 in Mycobacterial PathogenesisScandinavian Journal of Immunology, 2008
- Dynamic Changes in Pro- and Anti-Inflammatory Cytokine Profiles and Gamma Interferon Receptor Signaling Integrity Correlate with Tuberculosis Disease Activity and Response to Curative TreatmentInfection and Immunity, 2007
- T cell immune responses to mycobacterial antigens in Brazilian tuberculosis patients and controlsTransactions of the Royal Society of Tropical Medicine and Hygiene, 2005
- Tumor Necrosis Factor and Chemokine Interactions in the Formation and Maintenance of Granulomas in TuberculosisClinical Infectious Diseases, 2005
- Human Chemokines: An UpdateAnnual Review of Immunology, 1997
- An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.Journal of Experimental Medicine, 1993
- Role of tumor necrosis factor-α in disease states and inflammationCritical Care Medicine, 1993